Πέμπτη, 27 Μαΐου 2010

CancerCompass: New Data From Phase III Lung Cancer

CancerCompass: New Data From Phase III Lung Cancer Trial Show VeriStrat Identifies Patients Likely To Respond To Erlotinib

  © Blogger template 'Fly Away' by Ourblogtemplates.com 2008, mail@me

Back to TOP  

SYNC BLOGS
free website stats program